New patent for Mitsubishi Tanabe drug RADICAVA ORSBy DrugPatentWatch – Make Better Decisions / May 10, 2024 Annual Drug Patent Expirations for RADICAVA+ORS Radicava Ors is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from one supplier. There are four…Source